PFE - Pfizer Cisco Arch Capital And More: CNBC's 'Final Trades' | Benzinga
On CNBC's “Halftime Report Final Trades,” Joshua Brown of Ritholtz Wealth Management said he is staying long on Pfizer Inc. (NYSE:PFE).
On July 11, Pfizer announced it will advance the development of Danuglipron. The company selected the once-daily weight loss drug for continued advancement based on an ongoing pharmacokinetic study.
Bryn Talkington of Requisite Capital Management named Pacer US Cash Cows 100 ETF (CBOE: COWZ) as her final trade.
Don't forget to check out our premarket coverage here
Joe Terranova of Virtus Investment Partners picked ...